Press Release: CYBIN Closes Acquisition of Adelia Therapeutics; Bolsters Scientific Team and Grows IP Portfolio to 7 Patent Filings

CANNANNEW REPORT

Newly acquired novel psychedelic molecules diversify Cybin’s development portfolio, providing access to multiple future indications Adelia brings a range of technologies related to novel therapeutics, … Read More… The post Press Release: CYBIN Closes Acquisition of Adelia Therapeutics; Bolsters Scientific Team and Grows IP Portfolio to 7 Patent Filings first appeared on Cannabis Law Report.

Excerpt only …
READ MORE BELOW
Source : Press Release: CYBIN Closes Acquisition of Adelia Therapeutics; Bolsters Scientific Team and Grows IP Portfolio to 7 Patent Filings

reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.